Recent abolon transactions
Abolon advises on the sale of COAT-X, an innovator in high performance thin-film encapsulation technologies
Abolon has been the adviser to the shareholders of COAT-X, Switzerland, on its sale to the French surface functionalization and protection solutions provider Plasmalex group. The transaction has been closed on 25 April 2024. It was agreed not to disclose the purchase price. COAT-X is a leading solutions provider for high performance thin-film encapsulation technologies. The offering includes a broad range of parylene, ultra-tight multilayer and ALD barrier contract coating solutions and equipment to various industries ranging from medical technology over electronics to micromechanics.
Healthcare insights
How will new landmark legislation affect Germany’s private hospital groups
The new Hospital Structure Act could force small, low quality public sector hospitals to the wall. But it could also cap growth for big private operators. We examine likely scenarios.
Healthcare deal of the month
December 2015: Etac acquires Convaid
The Deal: In December 2015, Etac, a Sweden-based developer and manufacturer of mobility solutions and rehab products, acquired Convaid Products
WELCOME TO ABOLON
Abolon is a strategy consulting and corporate finance company with an exclusive focus on the healthcare sector.
We pride ourselves on our specialist insights into the various segments of the healthcare markets in Europe and beyond.
Our global network in the healthcare sector provides us with unmatched dealflow of large and mid-sized healthcare opportunities.
